Dialysis modality choice in elderly patients with end-stage renal disease: a narrative review of the available evidence

被引:33
|
作者
Segall, Liviu [1 ,2 ]
Nistor, Ionut [1 ,2 ]
Van Biesen, Wim [3 ]
Brown, Edwina A. [4 ]
Heaf, James G. [5 ]
Lindley, Elizabeth [6 ]
Farrington, Ken [7 ,8 ]
Covic, Adrian [1 ]
机构
[1] Univ Med & Pharm Gr T Popa, Dr CI Parhon Hosp, Dept Nephrol, Iasi, Romania
[2] Ghent Univ Hosp, ERBP, Ghent, Belgium
[3] Ghent Univ Hosp, Div Renal, Ghent, Belgium
[4] Hammersmith Hosp, Renal & Transplant Ctr, Imperial Coll, London, England
[5] Univ Copenhagen, Herlev Hosp, Dept Nephrol B, Herlev, Denmark
[6] Leeds Teaching Hosp NHS Trust, Dept Renal Med, Leeds, W Yorkshire, England
[7] Lister Hosp, Renal Unit, Stevenage, Herts, England
[8] Univ Hertfordshire, Dept Postgrad Med, Hatfield, Herts, England
关键词
elderly; end-stage renal disease; haemodialysis; peritoneal dialysis; survival; QUALITY-OF-LIFE; AUTOMATED PERITONEAL-DIALYSIS; REPLACEMENT THERAPY; COMPARING MORTALITY; CLINICAL-OUTCOMES; ESRD PATIENTS; HEMODIALYSIS; SURVIVAL; ACCESS; IMPACT;
D O I
10.1093/ndt/gfv411
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
The number of elderly patients on maintenance dialysis has rapidly increased in the past few decades, particularly in developed countries, imposing a growing burden on dialysis centres. Hence, many nephrologists and healthcare authorities feel that greater emphasis should be placed on the promotion of home dialysis therapies such as peritoneal dialysis (PD) and home haemodialysis (HD). There is currently no general consensus as to the best dialysis modality for elderly patients with end-stage renal disease. In-centre HD is predominant in most countries, although it is widely recognized that PD has several advantages over HD, including the lack of need for vascular access, continuous slow ultrafiltration, less interference with patients' lifestyle and lower costs. Comparisons of outcomes between elderly patients on PD and HD rely on observational studies, as randomized controlled trials are lacking. The results of these studies are variable. However, most of them suggest that survival rates are largely similar between the two modalities, except for elderly patients with diabetes and/or beyond 1-3 years from dialysis initiation, in which cases HD appears to be superior. An equally important aspect to consider when choosing dialysis modality, particularly in this age group, is the quality of life, and in this regard most studies found no significant differences between PD and HD. In these circumstances, we believe that dialysis modality selection should be guided by patient's preference, based on comprehensive and unbiased information. A multidisciplinary team should review elderly patients starting on dialysis, aiming to identify possible barriers to PD and home HD, including physical, visual, cognitive, psychological and social problems, and to overcome such barriers by adequate care, education, psychological counselling and dialysis assistance.
引用
收藏
页码:41 / 49
页数:10
相关论文
共 50 条
  • [11] Review of combination of peritoneal dialysis and hemodialysis as a modality of treatment for end-stage renal disease
    Fukui, H
    Hara, S
    Hashimoto, Y
    Horiuchi, T
    Ikezoe, M
    Itami, N
    Kawabe, M
    Kawanishi, H
    Kimura, Y
    Nakamoto, H
    Nakayama, M
    Ono, M
    Ota, K
    Shinoda, T
    Suga, T
    Ueda, T
    Fujishima, M
    Maeba, T
    Yamashita, A
    Yoshino, Y
    Watanabe, S
    Watanabe, T
    THERAPEUTIC APHERESIS AND DIALYSIS, 2004, 8 (01) : 56 - 61
  • [12] Factors Associated with the Choice of Peritoneal Dialysis in Patients with End-Stage Renal Disease
    Chiang, Pei-Chun
    Hou, Jia-Jeng
    Jong, Ing-Ching
    Hung, Peir-Haur
    Hsiao, Chih-Yen
    Ma, Tsung-Liang
    Hsu, Yueh-Han
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [13] Impact of dialysis modality on the survival of patients with end-stage renal disease and prior stroke
    I-Kuan Wang
    Wen-Miin Liang
    Cheng-Li Lin
    Yao-Lung Liu
    Chiz-Tzung Chang
    Tzung-Hai Yen
    Chiu-Ching Huang
    Fung-Chang Sung
    International Urology and Nephrology, 2016, 48 : 139 - 147
  • [14] THE EFFECTS OF DIALYSIS MODALITY UPON INFLAMMATION IN PREDIALYSIS END-STAGE RENAL DISEASE PATIENTS
    Yong, K.
    Dogra, G.
    Boudville, N.
    Lim, W.
    NEPHROLOGY, 2016, 21 : 47 - 48
  • [15] Effects of dialysis modality on mortality in patients with end-stage renal disease: A cohort study
    Du, Liang
    Sun, Heqi
    Lu, Jun
    Chen, Gang
    Ye, Jianming
    Zhuang, Ye
    Gao, Lanying
    Xiong, Yan
    SEMINARS IN DIALYSIS, 2023, 36 (02) : 155 - 161
  • [16] Impact of dialysis modality on the survival of patients with end-stage renal disease and prior stroke
    Wang, I-Kuan
    Liang, Wen-Miin
    Lin, Cheng-Li
    Liu, Yao-Lung
    Chang, Chiz-Tzung
    Yen, Tzung-Hai
    Huang, Chiu-Ching
    Sung, Fung-Chang
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (01) : 139 - 147
  • [17] Impact of dialysis modality on the survival of end-stage renal disease patients with or without cardiovascular disease
    Wang, I-Kuan
    Kung, Pei-Tseng
    Kuo, Wei-Yin
    Tsai, Wen-Chen
    Chang, Yi-Chih
    Liang, Chih-Chia
    Chang, Chiz-Tzung
    Yeh, Hung-Chieh
    Wang, Shu-Ming
    Chuang, Feng-Rong
    Wang, Kwua-Yun
    Lin, Ching-Yuang
    Huang, Chiu-Ching
    JOURNAL OF NEPHROLOGY, 2013, 26 (02) : 331 - 341
  • [18] Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients
    Shih, YCT
    Guo, A
    Just, PM
    Mujais, S
    KIDNEY INTERNATIONAL, 2005, 68 (01) : 319 - 329
  • [19] A Review of Sevelamer Hydrochloride in End-Stage Renal Disease Patients on Dialysis
    Spasovski, Goce
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 51 - 55
  • [20] Effects of dialysis modality choice on the survival of end-stage renal disease patients in southern China: a retrospective cohort study
    Zhiren He
    Haijing Hou
    Difei Zhang
    Yenan Mo
    La Zhang
    Guobin Su
    Junjie Lin
    Liming Lu
    Jingyao Huang
    Yewen Gu
    Ying Zhang
    Jingxia Lin
    Fengling Yuan
    Yu Peng
    Hui Liang
    Daixin Zhao
    Fuhua Lu
    Xusheng Liu
    Lixin Wang
    BMC Nephrology, 21